SmartMadeChinaCold Plasma Equipment for Air Disinfection, Wound Care and Medical Applications
National High-Tech Enterprise in Xi'an, Shaanxi, developing atmospheric-pressure cold plasma devices for human health, pet care and air purification
About the Manufacturer
Xi'an Lengdiankang Technology Co., Ltd. was established in November 2022 in Xi'an, Shaanxi Province. The company builds on the State Key Laboratory of Electrical Engineering at Xi'an Jiaotong University and on China's first plasma biomedical research centre, drawing on more than ten years of research and technology transfer work in the field. It is a national high-tech enterprise dedicated to the cold plasma health sector — a positioning the company describes as the first of its kind in China. Its core focus is the development of atmospheric-pressure cold plasma equipment and its medical applications. Product development to date covers plasma air disinfection units, plasma therapeutic devices, plasma-activated water systems and plasma cancer therapy devices, with demonstrated results in air disinfection and purification, skin disease treatment and wound disinfection and healing. The company has also extended its products to pet care scenarios, including air sterilisation and odour removal, wound healing and skin disease treatment. On the human health side, it is running clinical trials and certification work in aesthetics, refractory skin diseases, chronic ulcers and pain relief for advanced cancer.
Manufacturing Capabilities
The company operates from Xi'an, Shaanxi, and is built around a research and technology-transfer base linked to the State Key Laboratory of Electrical Engineering at Xi'an Jiaotong University and China's first plasma biomedical research centre. It holds national high-tech enterprise status and national science-and-technology SME status, and is recognised as an innovative SME in Shaanxi Province. It is listed on the specialised and innovative board of the Shaanxi Equity Exchange (stock code 900006) and has received strategic investment from Leaguer Kechuang (Shenzhen Main Board 002243), a Tsinghua-affiliated hard-technology incubation investor. The source profile does not disclose plant area, employee numbers, production line counts or monthly capacity; buyers should request these details directly.
Why Buyers Choose This Factory
- Rooted in the State Key Laboratory of Electrical Engineering at Xi'an Jiaotong University and China's first plasma biomedical research centre
- More than ten years of accumulated research and technology transfer in cold plasma, as stated in the company profile
- Focused product line built around atmospheric-pressure cold plasma technology rather than general-purpose electronics
- National high-tech enterprise, national science-and-technology SME and Shaanxi innovative SME status
- Listed on the specialised and innovative board of the Shaanxi Equity Exchange (stock code 900006)
- Strategic investment from Leaguer Kechuang (Shenzhen Main Board 002243)
- Recipient of Xi'an 'Scientist + Engineer' project support, an Excellence Award at the Ministry of Science and Technology's National Disruptive Technology Innovation Competition, second prize at the Qinchuangyuan Xi'an International Entrepreneurship Competition, and recognition in the China Innovation and Entrepreneurship Competition
- Featured in interviews by Shaanxi TV and CCTV, and selected for the China Innovation Brand Project
- Product applications span human health, pet care and air treatment, allowing buyers to source related plasma technologies from one supplier
Main Products
Factory Location
陕西 · 西安
OEM / ODM
OEM/ODM cooperation terms are not stated in the source materials. Buyers should confirm whether private-label or custom development is available directly with the supplier.
Frequently Asked Questions
When and where was the company founded?
Xi'an Lengdiankang Technology Co., Ltd. was established in November 2022 and is based in Xi'an, Shaanxi Province, China.
What does the company manufacture?
Its product range covers plasma air disinfection and odour elimination units, high-energy plasma field purification systems, cold plasma jet gun cabinets and plasma-activated water systems, together with plasma therapeutic devices and plasma cancer therapy devices developed for medical applications.
What technology platform does the company use?
The company focuses on atmospheric-pressure cold plasma equipment and its medical applications, developed through research linked to the State Key Laboratory of Electrical Engineering at Xi'an Jiaotong University and China's first plasma biomedical research centre.
What certifications and recognition does the company hold?
The company states that it is a national science-and-technology SME, a national high-tech enterprise and a Shaanxi innovative SME, and that it is listed on the specialised and innovative board of the Shaanxi Equity Exchange under stock code 900006.
Who has invested in the company?
Leaguer Kechuang (Shenzhen Main Board 002243), a Tsinghua-affiliated hard-technology incubation investor, has made a strategic investment in the company.
Are the human medical products approved for clinical use?
The company describes clinical trials and certification work as ongoing for human applications including aesthetics, refractory skin diseases, chronic ulcers and pain relief for advanced cancer. Approval status should be verified per product and per market with the supplier.
Profile data is from publicly disclosed company information. Registration is not the same as on-site inspection.